Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report.
J Cancer Prev
oregon; portland; chiles; Chemoprevention; Clinical trials; Immunomodulatory agents; Immunoprevention; Preventive vaccines
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the "Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents" as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.
Earle A. Chiles Research Institute
Mohammed, Altaf; Dashwood, Roderick H; Dickinson, Sally; Disis, Mary L; Jaffee, Elizabeth M; Johnson, Bryon D; Khleif, Samir N; Pollak, Michael N; Schlom, Jeffrey; Shoemaker, Robert H; Stanton, Sasha; Wondrak, Georg T; You, Ming; Zhu, Hao; and Miller, Mark Steven, "Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report." (2021). Articles, Abstracts, and Reports. 5782.